As Utah’s cannabis culture continues to unfold, the demand for well-informed policies and directives becomes increasingly evident. Enter the Medical Cannabis Policy Advisory Board, a vital yet often overlooked force molding the trajectory of the state’s medical cannabis program. Enacted through House Bill 72 during the 2023 legislative session, this board emerges as a guiding light for stakeholders navigating the intricate terrain of Utah’s blooming medical cannabis scene.
Composed of a diverse array of voices, spanning from medical professionals to law enforcement officials, the board embodies a rich tapestry of expertise essential for navigating the complexities of Utah’s medical cannabis landscape. Monthly meetings serve as a forum for robust discussions on policy matters, with recommendations channeled to pivotal bodies such as the Utah Department of Health and Human Services (DHHS) and the Utah Department of Agriculture and Food (UDAF). But what precisely are the roles and individuals shaping the decisions of this advisory board?
Among the esteemed members is Misty Smith, PhD, a seasoned researcher in behavioral pharmacology with over two decades of invaluable experience. Dr. Smith’s expertise lies in the meticulous evaluation of medical cannabis products’ safety and efficacy, making her a vital contributor to the board’s decision-making process. Alongside her stands Desiree Hennessy, the indefatigable director of the Utah Patients Coalition, championing tirelessly for patient rights and equitable access to cannabis-based treatments.
Representing the grassroots perspective is Nanette Berezhnyy, a parent navigating Utah’s medical cannabis program firsthand. Her insights offer invaluable clarity on the practical implications of policy decisions, rooted in personal experience as a medical cannabis patient and guardian. On the opposite end of the spectrum sits Kent Andersen, a public representative tasked with bridging the gap between policy and community interests.
Matthew Page, COO of Riverside Farms, provides a glimpse into the industry’s inner workings, steering discussions on cultivation and processing practices. His perspective is complemented by JD Lauritzen, an attorney versed in the intricacies of medical cannabis pharmacy operations. Together, they navigate the legal landscape, ensuring compliance while fostering a thriving cannabis market.
Law enforcement’s presence is not overlooked, with Deputy Commissioner Jimmy Higgs offering insights from the Utah Department of Public Safety. With a career spanning over two decades, Higgs brings a unique perspective, balancing public safety concerns with the evolving attitudes towards cannabis legalization. Meanwhile, Chris Morgan, an APRN specializing in psychiatric care, sheds light on the intersection between mental health and medical cannabis usage, advocating for holistic approaches to patient care.
Rounding out the board is Cami Clark, a CMHC and COO of Clinical Consultants, LLC, bringing expertise in substance abuse and mental health treatment. Her presence underscores the importance of addressing underlying mental health concerns within the context of medical cannabis usage, ensuring comprehensive support for patients.
The Medical Cannabis Policy Advisory Board operates with diligence, ensuring Utah’s medical cannabis program evolves with precision and care. Although their work often goes unnoticed, these dedicated individuals shape policies crucial to the well-being of patients statewide. Their commitment to collaboration and expertise drives progress toward a more informed, equitable, and compassionate approach to cannabis regulation in Utah. It’s worth noting that these meetings are open to the public, offering an opportunity for engagement and transparency. For those interested in attending, more information can be found at medicalcannabis.utah.gov.
